It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The hypothalamic-pituitary-adrenal (HPA) axis regulates responses to internal and external stressors. Many patients diagnosed with conditions such as depression or anxiety also have hyperactivity of the HPA axis. Hyper-stimulation of the HPA axis results in sustained elevated levels of glucocorticoids which impair neuronal function and can ultimately result in a psychiatric disorder. Studies investigating Glucocorticoid Receptor (GR/NR3C1) in the brain have primarily focused on the forebrain, however in recent years, the hindbrain has become a region of interest for research into the development of anxiety and depression, though the role of GR signalling in the hindbrain remains poorly characterised. To determine the role of glucocorticoid signalling in the hindbrain we have developed a novel mouse model that specifically ablates hindbrain GR to ascertain its role in behaviour, HPA-axis regulation and adrenal structure. Our study highlights that ablation of GR in the hindbrain results in excessive barbering, obsessive compulsive digging and lack of cage exploration. These mice also develop kyphosis, elevated circulating corticosterone and severe adrenal cortex disruption. Together, this data demonstrates a role for hindbrain GR signalling in regulating stress-related behaviour and identifies a novel mouse model to allow further investigation into the pathways impacting stress and anxiety.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 University of Edinburgh, The Queen’s Medical Research Institute, 47 Little France Crescent, MRC Centre for Reproductive Health, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); Faculty of Science, University of Newcastle, School of Environmental and Life Sciences, Callaghan, Australia (GRID:grid.266842.c) (ISNI:0000 0000 8831 109X)
2 University of Edinburgh, The Queen’s Medical Research Institute, 47 Little France Crescent, MRC Centre for Reproductive Health, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); Hugh Robson Building, George Square, Centre for Discovery Brain Sciences, Edinburgh, UK (GRID:grid.4305.2)
3 University of Edinburgh, The Queen’s Medical Research Institute, 47 Little France Crescent, MRC Centre for Reproductive Health, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
4 College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh Preclinical Imaging, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
5 Rigshospitalet, University of Copenhagen, Department of Growth and Reproduction, Copenhagen, Denmark (GRID:grid.475435.4); International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, Denmark (GRID:grid.475435.4)